Rotem Kedar, Ofra Sabag, Michal Licthenstein and Haya Lorberboum-Galski Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment Cancer 118
Article first published online: 12 JUN 2012 | DOI: 10.1002/cncr.27654
Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment. The sCD40L-caspase 3 chimeric protein efficiently and specifically kills malignant B cells by apoptosis.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.